Advertisement
Research ArticleDrug Discovery and Translational Medicine

Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase-Activating Peptide

Cristina Moldovan Loomis, Benjamin Dutzar, Ethan W. Ojala, Lee Hendrix, Charlie Karasek, Michelle Scalley-Kim, Jenny Mulligan, Pei Fan, Jens Billgren, Vanessa Rubin, Heidi Boshaw, Gayle Kwon, Sam Marzolf, Erica Stewart, David Jurchen, Susan M. Pederson, Lisa Perrino McCulloch, Brian Baker, Roger K. Cady, John A. Latham, Dan Allison and Leon F. Garcia-Martinez
Journal of Pharmacology and Experimental Therapeutics April 2019, 369 (1) 26-36; DOI: https://doi.org/10.1124/jpet.118.253443

Article Information

vol. 369 no. 1 26-36
DOI 
https://doi.org/10.1124/jpet.118.253443
PubMed 
30643015
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received September 7, 2018
  • Accepted December 27, 2018
  • Published online February 28, 2019.

Article Versions

Copyright & Usage 
Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Cristina Moldovan Loomis,
  2. Benjamin Dutzar,
  3. Ethan W. Ojala,
  4. Lee Hendrix,
  5. Charlie Karasek,
  6. Michelle Scalley-Kim,
  7. Jenny Mulligan,
  8. Pei Fan,
  9. Jens Billgren,
  10. Vanessa Rubin,
  11. Heidi Boshaw,
  12. Gayle Kwon,
  13. Sam Marzolf,
  14. Erica Stewart,
  15. David Jurchen,
  16. Susan M. Pederson,
  17. Lisa Perrino McCulloch,
  18. Brian Baker,
  19. Roger K. Cady,
  20. John A. Latham,
  21. Dan Allison, and
  22. Leon F. Garcia-Martinez
  1. Alder BioPharmaceuticals, Inc., Bothell, Washington
  1. Address correspondence to:
    Leon F. Garcia-Martinez, Alder BioPharmaceuticals, Inc., 11804 North Creek Parkway South, Bothell, WA 98011. E-mail: lgarcia-martinez{at}alderbio.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: January 2019 to December 2024

AbstractFullPdf
Jan 20192620157
Feb 20191526102
Mar 20192226376
Apr 20199922105
May 2019751279
Jun 2019791885
Jul 2019821689
Aug 201976989
Sep 2019631197
Oct 201911714122
Nov 20191392179
Dec 2019108824
Jan 202081924
Feb 202088614
Mar 202063340
Apr 202094733
May 2020112832
Jun 202064836
Jul 202064440
Aug 2020212743
Sep 2020124035
Oct 2020106734
Nov 2020125850
Dec 2020105134
Jan 202152337
Feb 2021134742
Mar 2021124237
Apr 2021113420
May 2021254239
Jun 202171617
Jul 202181933
Aug 202172425
Sep 2021274048
Oct 202154246
Nov 2021145260
Dec 202145333
Jan 202263244
Feb 202252132
Mar 2022114929
Apr 202284468
May 202252036
Jun 202293742
Jul 202273631
Aug 2022152523
Sep 2022114130
Oct 202284620
Nov 2022103440
Dec 202272024
Jan 2023104138
Feb 202375733
Mar 2023115167
Apr 202373457
May 2023103943
Jun 202334952
Jul 202365647
Aug 2023151640
Sep 2023155430
Oct 2023118552
Nov 2023716538
Dec 2023122452
Jan 20241258113
Feb 20241326234
Mar 202443055
Apr 20242210579
May 20241434043
Jun 202425144
Jul 202467656
Aug 2024147378
Sep 20241871136
Oct 2024917995
Nov 20241410553
Dec 2024106345

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleDrug Discovery and Translational Medicine

ALD1910, a Humanized Function-Modifying mAb against PACAP

Cristina Moldovan Loomis, Benjamin Dutzar, Ethan W. Ojala, Lee Hendrix, Charlie Karasek, Michelle Scalley-Kim, Jenny Mulligan, Pei Fan, Jens Billgren, Vanessa Rubin, Heidi Boshaw, Gayle Kwon, Sam Marzolf, Erica Stewart, David Jurchen, Susan M. Pederson, Lisa Perrino McCulloch, Brian Baker, Roger K. Cady, John A. Latham, Dan Allison and Leon F. Garcia-Martinez
Journal of Pharmacology and Experimental Therapeutics April 1, 2019, 369 (1) 26-36; DOI: https://doi.org/10.1124/jpet.118.253443
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement